Prudential Financial
TEVA icon

Prudential Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Prudential Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Sell
185,816
-21,340
-10% -$711K 0.01% 885
2026
Q1 		$6.24M Buy
207,156
+22,300
+12% +$717K 0.01% 826
2025
Q4 		$5.78M Buy
184,856
+18,276
+11% +$450K 0.01% 851
2025
Q3 		$3.36M Buy
166,580
+70,092
+73% +$1.23M ﹤0.01% 1118
2025
Q2 		$1.62M Buy
96,488
+36,983
+62% +$597K ﹤0.01% 1482
2025
Q1 		$915K Sell
59,505
-500,260
-89% -$8.94M ﹤0.01% 1613
2024
Q4 		$12.3M Buy
559,765
+112,352
+25% +$2.04M 0.02% 527
2024
Q3 		$8.06M Sell
447,413
-70,214
-14% -$1.23M 0.01% 768
2024
Q2 		$8.41M Sell
517,627
-174,150
-25% -$2.68M 0.01% 717
2024
Q1 		$9.76M Buy
691,777
+195,477
+39% +$2.46M 0.01% 695
2023
Q4 		$5.18M Buy
496,300
+376,581
+315% +$3.52M 0.01% 908
2023
Q3 		$1.22M Sell
119,719
-32,538
-21% -$303K ﹤0.01% 1661
2023
Q2 		$1.15M Sell
152,257
-124,555
-45% -$1.01M ﹤0.01% 1739
2023
Q1 		$2.45M Sell
276,812
-54,887
-17% -$543K ﹤0.01% 1206
2022
Q4 		$3.03M Buy
331,699
+167,474
+102% +$1.46M 0.01% 1104
2022
Q3 		$1.32M Buy
164,225
+123,595
+304% +$1.09M ﹤0.01% 1594
2022
Q2 		$323K Sell
40,630
-142
-0.3% -$1.24K ﹤0.01% 2313
2022
Q1 		$383K Sell
40,772
-5,613
-12% -$46.8K ﹤0.01% 2309
2021
Q4 		$427K Buy
46,385
+1,113
+2% +$10K ﹤0.01% 2264
2021
Q3 		$441K Sell
45,272
-116,885
-72% -$1.09M ﹤0.01% 2179
2021
Q2 		$1.6M Sell
162,157
-169,312
-51% -$1.79M ﹤0.01% 1582
2021
Q1 		$3.83M Buy
331,469
+150,390
+83% +$1.72M 0.01% 1144
2020
Q4 		$1.75M Sell
181,079
-105,083
-37% -$1.01M ﹤0.01% 1472
2020
Q3 		$2.58M Sell
286,162
-330,601
-54% -$3.5M ﹤0.01% 1218
2020
Q2 		$7.61M Buy
616,763
+52,129
+9% +$590K 0.01% 793
2020
Q1 		$5.07M Buy
564,634
+332,070
+143% +$3.4M 0.01% 906
2019
Q4 		$2.28M Hold
232,564
– – ﹤0.01% 1541
2019
Q3 		$1.6M Buy
232,564
+76,065
+49% +$583K ﹤0.01% 1678
2019
Q2 		$1.44M Buy
156,499
+14,952
+11% +$180K ﹤0.01% 1738
2019
Q1 		$2.22M Sell
141,547
-76,607
-35% -$1.35M ﹤0.01% 1562
2018
Q4 		$3.36M Buy
218,154
+111,847
+105% +$2.29M 0.01% 1256
2018
Q3 		$2.29M Buy
106,307
+8,096
+8% +$188K ﹤0.01% 1565
2018
Q2 		$2.39M Buy
98,211
+23,280
+31% +$475K ﹤0.01% 1560
2018
Q1 		$1.28M Sell
74,931
-1,876
-2% -$36.6K ﹤0.01% 1776
2017
Q4 		$1.46M Hold
76,807
– – ﹤0.01% 1713
2017
Q3 		$1.35M Sell
76,807
-1,166
-1% -$26.2K ﹤0.01% 1746
2017
Q2 		$2.59M Buy
77,973
+730
+0.9% +$22.6K ﹤0.01% 1442
2017
Q1 		$2.48M Sell
77,243
-100
-0.1% -$3.41K ﹤0.01% 1467
2016
Q4 		$2.8M Buy
+77,343
New +$3.09M ﹤0.01% 1380
2016
Q1 		– Sell
-22,900
Closed -$1.5M – 2326
2015
Q4 		$1.5M Hold
22,900
– – ﹤0.01% 1624
2015
Q3 		$1.29M Hold
22,900
– – ﹤0.01% 1664
2015
Q2 		$1.35M Buy
+22,900
New +$1.41M ﹤0.01% 1720
2013
Q4 		– Sell
-15,000
Closed -$567K – 2307
2013
Q3 		$567K Sell
15,000
-13,700
-48% -$534K ﹤0.01% 1915
2013
Q2 		$1.13M Buy
+28,700
New +$1.12M ﹤0.01% 1671

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Prudential Financial's TEVA Position: Q2 2026 in Review

Prudential Financial reduced its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, selling an estimated $711K and leaving 185,816 shares worth $6.3M. The position accounts for 0.01% of the portfolio, ranked #885.

Prudential Financial first reported a position in TEVA in Q2 2013 and has held it in 44 quarters since. The position peaked at $12.3M in Q4 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Prudential Financial held 185,816 shares of Teva Pharmaceuticals worth $6.3M as of Q2 2026.
  • Prudential Financial sold 21,340 Teva Pharmaceuticals shares in Q2 2026, an estimated $711K.
  • Teva Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #885 holding.
  • Prudential Financial first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
  • Prudential Financial's Teva Pharmaceuticals position peaked at $12.3M in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.